James Kasuboski is a highly accomplished and driven life science entrepreneur and investor. He has an extensive educational and professional background in molecular and cellular biology, having obtained a Ph.D. from the University of Notre Dame and a B.S. in Biology from Hillsdale College. With a focus on creating innovative and transformative healthcare solutions, Kasuboski has been a venture investor, consultant, and board member for several high-profile life science companies, including OMX Ventures, Enara Bio, Avilar Therapeutics, and Boehringer Ingelheim Venture Fund. He has also worked in various roles such as Director, Senior Associate Director, and Postdoctoral Research Fellow. Kasuboski's interests lie in identifying new and upcoming life science ventures, providing strategic support, and guiding these companies to achieve their full potential.